Sitemap - 2005 - The California Stem Cell Report
A Korean Lesson: 'Money Breeds Corruption'
California Stem Cell Director Stresses Speed
CIRM Scientific Conference Expenses Disclosed
Christmas Comes Early for Sen. Ortiz
California Stem Cell Leaders Speak to Korean Scandal
Korean Markets Warn Off Shy Stem Cell Investors
Korean News Fuels Fire Against CIRM
Bioethics Blog Weighs Hwang Damage
The Half Empty Implications of the Hwang Affair
Korean Mess Bad News for Funding of California Stem Cell Agency
Does the Korea-Egg Affair Give California More Stem Cell Clout?
Korea Herald: Hwang Faked Stem Cell Research
Should Women Be Allowed to Sell Their Eggs?
The Painful and Rocky California Stem Cell Experience
Searching for Stem Cell News in All The Wrong Places
Zach Hall Critiques Sacramento Bee Editorial
NY Times Looks at Beleaguered CIRM
Spending on Litigation Seems to Please Stem Cell Foes
Klein Discusses Korea Trip and Other Matters
Depositions Could Be Illuminating
U. of Pittsburgh and the Schatten/Hwang Affair
Tiny Turnout at Stem Cell Agency Meetings
Reviewing Today's Coverage of the Stem Cell Agency
Foxes, Chickens and Stem Cells
Stem Cell Trial Date Set, Legal Coffers Replenished
IP Proposals Not Likely to Satisfy
Tight Budget, Hiring Freeze for CIRM
CIRM Contracts Hit $1.8 Million
The Voices of the Stem Cell Barristers
Another Year for Legal Squabbling
Conflicts and Records Targeted by CIRM Foes
Judge Sets High Hurdle for Stem Cell Foes
Hwang Denies Patent Demand Report
CIRM Survives Initial Court Test
A Sad Tale of Stem Cell Conflicts?
Eggs and Ethics: CIRM's Proposed Rules
The Korean Lesson: More Sunshine Needed in California
Klein Speaks at Stanford Conference
Klein Says He Knew about Federal Tax Problem Prior to Election
Klein's Silence Ill Serves Stem Cell Agency
Looking for Stem Cell Research Money?
Unanswered Questions about Stem Cell Research and IP
Stem Cell Training Grant Program Stalls
New Water Fountains for Stem Cell Science
More Reporting from Monday's IP Hearing
Whoops! Monday's IP Hearing Generates a Story
New Report: Too Soon To Tell About CIRM?
Ortiz: CCST IP Report Tilted by Insiders
FTCR: Affordable Therapy, Strong Public Oversight, Diverse Research
Sharing the Stem Cell Wealth (Assuming There Is Some)
Text of Legislative Staff Report on IP Issues and Prop. 71
Stem Cell IP Slated for More Critical Look
Chronicle: Klein Failed to Disclose Royalty Problem with Prop. 71
Chronicle Primer on Stem Royalty Issue
Proposal for a California Stem Cell Venture Fund
"Big-headed?" -- Stem Cell Perspective from South Korea
"The Right to Be Cured, Quickly"
Will California Produce Biology's Holy Grail?
California and the South Korean Stem Cell Network
Soothing Anxieties in the Stem Cell Sector
The Higher the Risk, the Higher the Reward?
CIRM Lawsuit Filings Available
Stem Cell Showdown in Apricot City
Stem Cell Legislation to Rise Again
Low Hanging Fruit vs. Embryonic Stem Cell Research
Villains, Big Pharma and Stem Cell Research
The Bee: Stem Cell Conference Wise, But CIRM Leaders Still Bogus on Disclosure
“Everything” Targeted in Stem Cell Research
Want a Stem Cell Grant? Here Are Some Clues, Sort Of
Otis Aims at Stem Cell Report; Governor Nixes SB18
Stem Cell Science: Glue Your Ears to the Internet
CIRM Stalls Again on Mystery Costs
Mystery Spending at CIRM's Scientific Conference
Too Much Inside-The-Box Thinking From CIRM
Bustamante Names New Stem Cell Overseer
Reviewers Unaware of Funding Shortfall?
Stem Cell Discussions on Saturday
CIRM System: Convoluted and Opaque?
More Favorable PR Stems From Training Grants
Serrano Sewell Demures on Stem Cell Report Item
Greenlining Enters Fray with Emphasis on Minorities
Peddling the Name of the Stem Cell Scholar Program
Coverage is Right Medicine for Stem Cell Agency
CIRM Hands Out $39 Million (sort of), Picks Almost New President
Telling Drama Promised at Big Tomato Meeting
Bowdlerization and Sleazy Speculation
Time for a Little More Explanation
Identifying (sort of) Winners and Losers in the First Stem Cell Grants
Columnist says CCST Royalty Position OK
Inside the Stem Cell Agency's Spending Plans
The Bee: Golden State Deserves More from Stem Cell Research
Klein Twits The Sacramento Bee
The California Stem Cell Gorilla
Lean Coverage of Big Bucks Issue
Who Benefits from Stem Cell IP?
Stem Cell IP Report Negative on Royalty Sharing, Favorable Pricing
IP Report Released for California Stem Cell Agency
Young Klein: "I'm going to stay away from government work."
New Service Added to the Report
Sacramento Stem Cell Conference Requires Disclosure
The Bee: Nonprofit Control of CIRM?
"Secret" Stem Cell Info Disclosed by Stanford
Edelman Earmarks on CIRM Press Notices
WSJ: Scandals in Medical Research
Secrecy and the Public's Money
Baybio Stem Cell Show and Tell
Dog Days for US Stem Cell Science?
Latest on CIRM Presidential Search
CIRM Launches Major Stem Cell Conference
Political Conflagrations and the Biotech Boom
Stem Cell Star Rebuffs the Golden State
The Boodle, The Barristers and a Glass Half-Full
The Retroactive $378,000 Edelman PR Contract
Talent, Mumbo-Jumbo and $536,000 Salaries
At Sea Again: Intermittent Postings Likely
Setting The Record Straight: Less Than Bleak Climate
Roger's Reality Check: Polarization, Backlashes and Mistakes
Following the Stem Cell Money Trail
The $30,000-a-month PR contract: What's it Worth?
Stem Cells and Behind the Scenes Decision Making
Transparency and Stem Cell "Hooey"
Notes From Nature: Predicting Stem Cell Winners
Transparency, Money and Management
CIRM's Million Dollar Outside Contracts
Intermittent Reports: Wandering the Sea of Cortez
Rebel Stem Cell Directors Not Happy with Klein
Gurgling as Money and Brains Drain to the West
Stronger CIRM Standards Attract Little Notice
New Jersey Lessons for California
California "Gold Rush" Discussions at Stem Cell Conferences
No Nasty Fall Election on Stem Cell Agency
Correction on Pomeroy Position
Murky Money Matters, Disgruntled Directors
Upcoming: More on the Stem Cell Agency's Budget
Stem Cell Stakeholders Need the Financial Skinny
More on Reality: Summoning Up the Troops
Reality Check on a "Recipe for Trouble"
Special Insights vs. Possible Special Interests
A Retrospective on Prop. 71 in Houston
The Bee: State Bond Counsel Says No SCA13 Problem
Chron Makes Stem Cell News Easier to Find
Public Posturing, the "Trust Us" Position and Industry Ties
SCA13: Current and Planned Amendments
Cash Rolls In, Contracts Roll Out
Ortiz To Address CIRM Monday Morning
The Bridge Loan Plan: A Few More Details
Competition for Creation of a Stem Cell Cadre
How to Criticize This Blog and Other Matters
SCA13 Delayed, SB18 Advances to Assembly
Patient Group Members Mobilize Against SCA13
Californians Need Information Not Ballyhoo
The Blasto-Sisyphean Stem Cell Exercise
Stem Cell Dress of The Day: Thick Skin
The Bee: No Compromise on Ballot Measure
Klein: Haste Poses Peril to Agency
Not For Everybody: Details of CIRM's Analysis of SCA13
Text of CIRM Analysis of SCA13
Klein, Ortiz Agree on SCA 13 Changes, But Differences Remain
SCA 13: A Yeah and a Compromise
Stem Cell Agency Lambastes Ortiz
Political Interference, Venture Capitalists and a Personal Plea
The Bee Roasts Robert Klein as "Rogue Operator"
Preciado Resigns from Stem Cell Agency
Stem Cell Snippets: Solace and Legislation
Stem Cell Ballot Measure Moves Ahead
Push for Ballot Review of Stem Cell Agency
Robert Klein, Rube Mayors and Arrogrance
The Worst of Beasts or The Best of Beasts?
More on CIRM Presidential Candidates
California Stem Cell Legislation Amended
The Bridge to Three Billion Dollars
State Legislative Hearing May 16 on Stem Cell Measure
Rich and Rounded....That's the Way It Is
The "Murkier" $100 Million Workaround
HQ: The Final Dissection(Maybe)
Looking for a $100 Million Helping Hand
The (Almost) Final HQ Media Morsels
Looking at the Stem Cell Players
The $10,000-a-Month Stem Cell Lobbyist
Who's on Second: Sacramento and San Diego
Surprise: San Francisco Gets the Nod
Managing Stem Cell Expectations
Penhoet, Selling and Management
The Bee: Sad Situation At CIRM
HQ Countdown: Tittering and Cheesiness
Is the River City Bid Underwater?
Venturing into the Stem Cell Business
Will the New Stem Cell CEO Be a Surfer?
The Edelman Blog and Government PR
Ho-Hum. Stem Cell Measures Approved
The Stem Cell Agency Just Says No
Looking for Analysis in the Right Places
Ortiz Drops Superovulation Moratorium
Stem Cell Snippets: Dudes to Brownback
Will California Vote Again on Stem Cell Research?
International Stem Cell Soiree
The Tin Ear of the Private Sector
Light Coverage of Thursday's Meeting
Critics: Conflict Code Not Up to Snuff
More Information, More Complaints
Difficult Questions: Eggs to FDA
Citizen-bioethicists and Stem Cells
Business, Politics, Stem Cells and Steve Westly
The Fallacy of the Will of the People
Lee-Halpern Petition Rejected by Klein
Blogosphere Simmers with Stem Cell Commentary
Two Critical Views of the Stem Cell Agency
Odd Couple Tightens Oversight Efforts.
Roiling Undercurrents on Klein
California Stem Cell 101 -- Must Reading
Background From Legislative Hearing
Thorny Super-ovulation Question
Small Profit in Stiffing Lawmakers
Stem Cell Agency Rebuts Critics in Capitol
Complete Texts for Legislative Hearing into Stem Cell Agency
Genetics and Society Media Advisory
Semi-Complete Coverage Coming Up on Ortiz Hearing
New Frontiers: Stem Cells and the Web
Fiber Optics and 300 Square Foot Offices
Is $389,000 Too Much for "John the Baptist?"
Ethics: From Compensation to Informed Consent
Working Groups Akin to Legislative Committees
More Legislative Pressure on CIRM
Mighty Full Plate Next Tuesday
Ten Thousand Emerging Realities
Overcoming Short-term Thinking
Web-casting for CIRM Proceedings?
Bedtime Reading Posted at CIRM
About $90 million in First Round Grants
Tough CIRM Application Disappears
Reaction to Chiron-Wareham Link Piece
Legislative hearings scheduled for March 2
CIRM Landlord Says It Linked to Chiron
CIRM Sayings: Cowboys and Hell to Pay
Prop. 71 Campaign Spends nearly $35 million
Hiring and Appearances, Integrity and Bags of Swag
New Legislative Subcommittee For CIRM
CIRM's New HQ? The CEO reality
Solitary Update on Presidential Search
LA Times to CIRM Cynics: Stand Aside!
A Missed Deadline: What Does It Mean?
Klein Profile, Congress Thwarting?
Meeting, Meetings, Meetings, But More is Needed
Good Enough for the Golden State?
CIRM Waits on National Research Standards